FindTrial
Sign In

Comparing the effects of Microneedling assisted iPRF with and without hyaluronic acid for the treatment of maxillary black triangles

Comparative Evaluation of Microneedling Assisted iPRF with and without Hyaluronic acid 2 percent Management of Anterior Maxillary Black Triangles A split mouth randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091866
Enrollment
40
Registered
2025-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K060- Gingival recession

Interventions

Intervention1: Microneedling assisted iprf with hyaluronic acid 2 percent: Microneedling assisted iprf with hyaluronic acid 2 percent when used in maxillary anterior black triangles leads to enhanced

Sponsors

self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Systemically healthy patients aged 20 to 75 years Patient with healthy and stable soft tissue architecture Patients presenting with Class 0 1 and 2 interdental papillary loss in the anterior maxilla as defined by the Jemt Papillary Index 1994 Patients with a probing depth of less than 4 mm Patients with a gingival and plaque index of 0 to 1

Exclusion criteria

Exclusion criteria: Patients with systemic diseases that would have influenced bone or soft tissue metabolism Pregnant or lactating females Tobacco smokers. Patient with a history of periodontal surgery in the last six months Patients treated with any medication known to cause gingival hyperplasia Patients with a history of allergic reactions drug and alcohol abuse

Design outcomes

Primary

MeasureTime frame
To evaluate the Papillary Fill using JemtPapillary Index 1977 at baseline To evaluate the Papillary gain using Jemt Papillary Index 1977 at 1 3 and 6 months post treatment. To measure the Papillary Width PW at baseline and 1 3 and 6 months post treatment To evaluate the Papillary Deficient Height PH at baselineand 1 3 and 6 months post treatment To estimate the area of the black triangle AoP at baseline and 1 3 and 6 months post treatmentTimepoint: To evaluate the Papillary Fill using JemtPapillary Index 1977 at baseline To evaluate the Papillary gain using Jemt Papillary Index 1977 at 1 3 and 6 months post treatment. To measure the Papillary Width PW at baseline and 1 3 and 6 months post treatment To evaluate the Papillary Deficient Height PH at baselineand 1 3 and 6 months post treatment To estimate the area of the black triangle AoP at baseline and 1 3 and 6 months post treatment—

Secondary

MeasureTime frame
To evaluate patient reported outcomes at baseline and 6 months using VAS pain assessment scale and a questionnaire Timepoint: 1 3 and 6 months—

Countries

India

Contacts

Public ContactDr Vrushali Lathiya

Ranjeet Deshmukh Dental College and Research Centre, Hingna, Nagpur

drvrushalilathiya@gmail.com09561100520

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026